PGT-M Preimplantation Genetic Testing for Monogenic disorders

Prevent the transmission of single gene disorders to future children and achieve a healthy pregnancy

PGT-M
Benefits
Indications

What is PGT-M test?

PGT-M (formerly PGD) is an early genetic diagnosis test for embryos produced during IVF, prior to their transfer to the uterus.

By analysing DNA from each embryo, normal embryos can be preferentially selected to be transferred and begin the journey towards conceiving a healthy child.

What is the procedure?

Why should use PGT-M test?

PGT-M is indicated for couples with personal or familial high-risk for single gene conditions including Cystic Fibrosis, Fragile-X syndrome, Muscular dystrophy,
Huntington’s disease, and others.

Who should use PGT-M test?

Patients who are undergoing an assisted reproduction treatment and have a personal or familial high-risk for single gene conditions. This risk may be identified due to:
A family history of these conditions
A positive carrier screening result
A previous affected child

Download full disease list

Test limitations

Limitations of PGT-M can arise from the IVF treatment itself. For example, poor ovarian stimulation can reduce the likelihood of identifying a healthy embryo, since PGT-M success is linked to the number of high-quality eggs and embryos produced in the cycle.
PGT-M provides no guarantee of a completely healthy baby. If a couple is at high risk of transmitting a particular disease to their offspring, PGT-M significantly minimises this risk. However, there remains a small risk of misdiagnosis due to technical limitations, such as contamination, recombination and ADO. Couples should always be offered the possibility of prenatal diagnosis to confirm results. It is important to know that PGT-M will test for the specific mutation requested, but no other genes or mutations are analyzed, even if they are located within the same gene.
In some countries there can be legal limitations. The laws regulating PGT-M vary by country. In some countries, its use is prohibited or tightly regulated and might require, for some indications, a case-by-case authorization by a National Committee.

Documentation

PGT-M Specialists' documents

Technical Sheets

Download

Brochure

Download

Scientific evidence

Relevant related studies:

G. Kakourou et al., The clinical utility of PGD with HLA matching a collaborative multi-centre ESHRE study. Human Reproduction, Vol.33, No.3 pp. 520–530. Fertility and Sterility

M De Rycke, et al., ESHRE PGD Consortium data collection XIV–XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013, Human Reproduction, Volume 32, Issue 10, October 2017, Pages 1974–1994.

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

Learn more about Igenomix

Other services you may be interested

CGT

Determines the risk of having a child with a genetic disease

More information

PGT-A

Chromosomally normal
embryos selection

More information

NACE

Minimizes unnecessary amniocentesis

More information

Sex selection and Sex determination, before and after conception is prohibited and punishable under PC & PNDT act no. 57 of 1994

Igenomix is in the media

IGENOMIX has not affiliated any news outlet or publication identified above. News coverage does not constitute an endorsement of IGENOMIX or its products

Igenomix has performed more than 1300 PGT-M cycles

Options for combined
PGT-M+PGT-A

Our PGT-M testing is 98% accurate.

Accredited testing
in a UK laboratory

What is PGT-M test?

What is the procedure?

Why should use PGT-M test?

Who should use PGT-M test?

Test limitations

Technical Sheets

Brochure

Relevant related studies:

Can we help you?

Igenomix and fertility

CGT

PGT-A

NACE

Igenomix is in the media

PGT-M Preimplantation Genetic Testing for Monogenic disorders

Prevent the transmission of single gene disorders to future children and achieve a healthy pregnancy

Igenomix has performed more than 1300 PGT-M cycles

Options for combined PGT-M+PGT-A

Our PGT-M testing is 98% accurate.

Accredited testing in a UK laboratory

What is PGT-M test?

What is the procedure?

Why should use PGT-M test?

Who should use PGT-M test?

Test limitations

Technical Sheets

Brochure

Relevant related studies:

Can we help you?

Igenomix and fertility

Other services you may be interested

CGT

PGT-A

NACE

Igenomix is in the media

Options for combined
PGT-M+PGT-A

Accredited testing
in a UK laboratory